130 related articles for article (PubMed ID: 20185000)
1. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
2. Body Mass Index and Sudden Cardiac Death in Japanese Patients After Acute Myocardial Infarction: Data From the JCAD Study and HIJAMI-II Registry.
Shiga T; Kohro T; Yamasaki H; Aonuma K; Suzuki A; Ogawa H; Hagiwara N; Yamazaki T; Nagai R; Kasanuki H
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982233
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
Hess PL; Laird A; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Hall WJ; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Al-Khatib SM; Piccini JP; Inoue LY; Sanders GD
Heart Rhythm; 2013 Jun; 10(6):828-35. PubMed ID: 23416381
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
Shun-Shin MJ; Zheng SL; Cole GD; Howard JP; Whinnett ZI; Francis DP
Eur Heart J; 2017 Jun; 38(22):1738-1746. PubMed ID: 28329280
[TBL] [Abstract][Full Text] [Related]
5. The association between GRACE score at admission for myocardial infarction and the incidence of sudden cardiac arrests in long-term follow-up - the MADDEC study.
Hautamäki M; Järvensivu-Koivunen M; Lyytikäinen LP; Eskola M; Lehtimäki T; Nikus K; Oksala N; Tynkkynen J; Hernesniemi J
Scand Cardiovasc J; 2024 Dec; 58(1):2335905. PubMed ID: 38557164
[No Abstract] [Full Text] [Related]
6. Regional disparities and risk factors of mortality among patients at high risk of sudden cardiac death in emerging countries: a nonrandomized controlled trial.
Zhao S; Ching CK; Huang D; Liu YB; Rodriguez-Guerrero DA; Hussin A; Kim YH; Van Dorn B; Zhou X; Singh B; Zhang S;
BMC Med; 2024 Mar; 22(1):130. PubMed ID: 38519982
[TBL] [Abstract][Full Text] [Related]
7. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death.
Kelesidis I; Travin MI
J Nucl Cardiol; 2012 Feb; 19(1):142-52; quiz 153-7. PubMed ID: 22130965
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for mortality in post-myocardial infarction patients: insights from the improve SCA bridge study.
Kumar D; Bardooli F; Chen WJ; Huang D; Sankardas MA; Ahmed WH; Liew HB; Gwon HC; Van Dorn B; Holmes T; Thompson A; Zhang S
Egypt Heart J; 2024 Jun; 76(1):72. PubMed ID: 38849606
[TBL] [Abstract][Full Text] [Related]
9. When to implant an ICD following a myocardial infarction?
Hess PL; Al-Khatib SM; Inoue LY; Sanders GD
Heart Rhythm; 2013 Sep; 10(9):e79. PubMed ID: 23891957
[No Abstract] [Full Text] [Related]
10. ICD early after myocardial infarction: it is really necessary to wait 40 days before implantation?
Bellicini MG; Cersosimo A; Cerini M; Bontempi L; Curnis A; Arabia G
J Interv Card Electrophysiol; 2024 Apr; 67(3):439-441. PubMed ID: 38099975
[TBL] [Abstract][Full Text] [Related]
11. Relationship between extreme obesity and mortality in patients with reduced ejection fraction.
Siegel RM; Ostfeld RJ; Aboodi MS; Vittorio TJ; Mehlman Y; Travin MI
J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):279-284. PubMed ID: 33633043
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication to predict sudden cardiac death in patients with acute myocardial infarction and left ventricular dysfunction.
Hayashi T; Kataoka N; Imamura T
J Cardiol; 2023 Dec; 82(6):504. PubMed ID: 37640153
[No Abstract] [Full Text] [Related]
13. Complications of cardiac implantable electronic device placement in public and private hospitals.
Ganesan AN; Moore K; Horton D; Heddle W; McGavigan AD; Hossain S; Ali A; Hariharaputhiran S; Ranasinghe I
Intern Med J; 2020 Oct; 50(10):1207-1216. PubMed ID: 31762133
[TBL] [Abstract][Full Text] [Related]
14. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
15. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.
Zeitler EP; Friedman DJ; Loring Z; Campbell KB; Goldstein SA; Wegermann ZK; Schutz J; Smith N; Black-Maier E; Al-Khatib SM; Piccini JP
Heart Rhythm; 2020 Mar; 17(3):447-454. PubMed ID: 31561032
[TBL] [Abstract][Full Text] [Related]
16. Replacement of an Implantable Cardioverter-Defibrillator (ICD) with a New Standard Subcutaneous ICD System in a Patient with Jervell and Lange-Nielsen Syndrome.
Sato A; Hasegawa Y; Haniu H; Shiraishi S; Yagihara N; Iijima K; Izumi D; Minamino T
Int Heart J; 2019 Sep; 60(5):1206-1210. PubMed ID: 31484877
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.
Echouffo-Tcheugui JB; Masoudi FA; Bao H; Curtis JP; Heidenreich PA; Fonarow GC
Eur J Heart Fail; 2019 Sep; 21(9):1093-1102. PubMed ID: 31359595
[TBL] [Abstract][Full Text] [Related]
18. Association Between Body Mass Index and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement (TAVR) with Edwards SAPIEN™ 3 TAVR Valves: A Single-Center Experience.
Ahmad M; Patel JN; Loc BL; Vipparthy SC; Divecha C; Barzallo PX; Kim M; Baman T; Barzallo M; Mungee S
Cureus; 2019 Jul; 11(7):e5142. PubMed ID: 31328076
[TBL] [Abstract][Full Text] [Related]
19. PECS block for an ICD implantation in the super obese patient.
Pai B H P; Shariat AN; Bhatt HV
J Clin Anesth; 2019 Nov; 57():110-111. PubMed ID: 30965271
[No Abstract] [Full Text] [Related]
20. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
